A polymer coating applied to Salmonella prevents the binding of Salmonella‐specific antibodies
Authors:
- 27 June 2012
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 132 (3) , 717-725
Abstract
The use of Salmonella as a potential antitumor agent has been investigated, but innate immunity against this bacterium reduces the efficacy of its tumor‐targeting and antitumor activities. The purpose of this study was to investigate the modulation of the tumor‐targeting efficiency of Salmonella enterica serovar choleraesuis by modifying the immune response to these bacteria by coating them with poly(allylamine hydrochloride) (PAH), designated PAH‐S.C. To evaluate this modulation, we used naïve mice and mice immunized with Salmonella to study the role of the preexisting immune response to the antitumor activity of PAH‐S.C. When anti‐Salmonella antibodies were present, the invasion activity, cytotoxicity, and gene transfer of Salmonella was significantly decreased, both in vitro and in vivo. Treatment with PAH‐S.C. resulted in delayed tumor growth and enhanced survival in immunized mice. Furthermore, immunohistochemical studies of the tumors revealed the infiltration of neutrophils and macrophages in immunized mice treated with PAH‐S.C. These results indicate that Salmonella encapsulation effectively circumvented the Salmonella‐specific immune response.Keywords
This publication has 32 references indexed in Scilit:
- Bacteria-Induced Gap Junctions in Tumors Favor Antigen Cross-Presentation and Antitumor ImmunityScience Translational Medicine, 2010
- Tissue-specific gene delivery via nanoparticle coatingBiomaterials, 2010
- Layer-by-layer coating of bacteria with noble metal nanoparticles for surface-enhanced Raman scatteringAnalytical and Bioanalytical Chemistry, 2009
- Humoral Immune Responses Inhibit the Antitumor Activities Mediated by Salmonella enterica Serovar choleraesuisJournal of Immunotherapy, 2009
- Living Fungi Cells Encapsulated in Polyelectrolyte Shells Doped with Metal NanoparticlesLangmuir, 2009
- Enhancement of humoral and cellular immune responses by an oral Salmonella choleraesuis vaccine expressing porcine prothymosin αVaccine, 2005
- Systemic administration of attenuated Salmonella choleraesuis in combination with cisplatin for cancer therapyMolecular Therapy, 2005
- Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimuriumProceedings of the National Academy of Sciences, 2005
- Endostatin gene therapy delivered by Salmonella choleraesuis in murine tumor modelsThe Journal of Gene Medicine, 2004
- Lipid A mutant Salmonella with suppressed virulence and TNFα induction retain tumor-targeting in vivoNature Biotechnology, 1999